Vitamin D and lung development in early life

Vitamin D and the Lung: Mechanisms and Disease Associations

Volumn , Issue , 2012, Pages 41-57

  Rehan, Virender K ^a   Torday, John S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alveolar lung development; Childhood; Early life; Epithelial mesenchymal interactions; Lipo fi broblastic phenotype; Lung development; Paracrine model; Vitamin D

Indexed keywords

EID: 84897063044     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-61779-888-7_3     Document Type: Chapter

References (106)

1. Shannon JM, Hyatt BA. Epithelial-mesenchymal interactions in the developing lung. Annu Rev Physiol. 2004;66:625-45.
2. Torday JS, Rehan VK. A cell-molecular approach predicts vertebrate evolution. Mol Biol Evol. 2011;28(11):2973-81.
3. Burri PH. Development and growth of the human lung. Comp Physiol. 2011;1-46 [Published online 1 Jan 2011, doi:10.1002/cphy.cp030101].
4. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev. 2006;27(2):141-69.
5. Torday JS, Rehan VK. A paracrine model for lung development, disease, and treatmentperspective. Pediatr Res. 2007;62(1):2-7.
6. Smith BT, Post M. Fibroblast-pneumocyte factor. Am J Physiol. 1989;257(4 Pt 1):L174-8.
7. Kaplan NB, Grant MM, Brody JS. The lipid interstitial cell of the pulmonary alveolus. Age and species differences. Am Rev Respir Dis. 1985;132(6):1307-12.
8. Torday J, Hua J, Slavin R. Metabolism and fate of neutral lipids of fetal lung fibroblast origin. Biochim Biophys Acta. 1995;1254(2):198-206.
9. Torday JS, Sun H, Qin J. Prostaglandin E2 integrates the effects of fluid distension and glucocorticoid on lung maturation. Am J Physiol. 1998;274(1 Pt 1):L106-11.
10. Senior PV, Heath DA, Beck F. Expression of parathyroid hormone-related protein mRNA in the rat before birth: demonstration by hybridization histochemistry. J Mol Endocrinol. 1991;6(3):281-90.
11. Karperien M, van Dijk TB, Hoeijmakers T, et al. Expression pattern of parathyroid hormone/ parathyroid hormone related peptide receptor mRNA in mouse postimplantation embryos indicates involvement in multiple developmental processes. Mech Dev. 1994;47(1):29-42.
12. Yamamoto M, Harm SC, Grasser WA, Thiede MA. Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch. Proc Natl Acad Sci USA. 1992;89:5326-30.
13. Daifotis AG, Weir EC, Dreyer BE, Broadus AE. Stretch-induced parathyroid hormone-related peptide gene expression in the rat uterus. J Biol Chem. 1992;267:23455-8.
14. Rubin LP, Kovacs CS, De Paepe ME, Tsai SW, Torday JS, Kronenberg HM. Arrested pulmonary alveolar cytodifferentiation and defective surfactant synthesis in mice missing the gene for parathyroid hormone-related protein. Dev Dyn. 2004;230:278-89.
15. Rubin LP, Kifor O, Hua J, Brown EM, Torday JS. Parathyroid hormone (PTH) and PTHrelated protein stimulate surfactant phospholipid synthesis in rat fetal lung, apparently by a mesenchymal-epithelial mechanism. Biochim Biophys Acta. 1994;1223:91-100.
16. Torday JS, Sanchez-Esteban J, Rubin LP. Paracrine mediators of mechanotransduction in lung development. Am J Med Sci. 1998;316:205-8.
17. Gao J, Serrero G. Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake. J Biol Chem. 1999;274: 16825-30.
18. Schultz CJ, Torres E, Londos C, Torday JS. Role of adipocyte differentiation-related protein in surfactant phospholipid synthesis by type II cells. Am J Physiol Lung Cell Mol Physiol. 2002;283:L288-96.
19. Torday J, Rehan V. Neutral lipid traf ficking regulates alveolar type II cell surfactant phospholipid and surfactant protein expression. Exp Lung Res. 2011;37:376-86.
20. Torday JS, Sun H, Wang L, Torres E, Sunday ME, Rubin LP. Leptin mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation. Am J Physiol Lung Cell Mol Physiol. 2002;282:L405-10.
21. Torday JS, Rehan VK. Stretch-stimulated surfactant synthesis is coordinated by the paracrine actions of PTHrP and leptin. Am J Physiol Lung Cell Mol Physiol. 2002;283:L130-5.
22. Cossu G, Tajbakhsh S, Buckingham M. How is myogenesis initiated in the embryo? Trends Genet. 1996;12:218-23.
23. Ross SE, Hemati N, Longo KA, et al. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289:950-3.
24. Elberg G, Gimble JM, Tsai SY. Modulation of the murine peroxisome proliferator-activated receptor gamma 2 promoter activity by CCAAT/enhancer-binding proteins. J Biol Chem. 2000;275:27815-22.
25. Moreno-Aliaga MJ, Matsumura F. Endrin inhibits adipocyte differentiation by selectively altering expression pattern of CCAAT/enhancer binding protein-alpha in 3T3-L1 cells. Mol Pharmacol. 1999;56:91-101.
26. Hauser S, Adelmant G, Sarraf P, Wright HM, Mueller E, Spiegelman BM. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J Biol Chem. 2000;275:18527-33.
27. Novak A, Dedhar S. Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci. 1999; 56:523-37.
28. Campos RV, Asa SL, Drucker DJ. Immunocytochemical localization of parathyroid hormonelike peptide in the rat fetus. Cancer Res. 1991;51:6351-7.
29. Rubin LP, Kifor O, Hua J, Brown EM, Torday JS. Parathyroid hormone (PTH) and PTHrelated protein stimulate surfactant phospholipid synthesis in rat fetal lung, apparently by a mesenchymal-epithelial mechanism. Biochem Biophys Acta. 1994;1223:91-100.
30. Woodgett JR. Judging a protein by more than its name: gsk-3. Sci STKE. 2001;2001 (100):RE12.
31. Kovala T, Lorimer lA, Brickenden AM, Ball EH, Sanwal BD. Protein kinase A regulation of cAMP phosphodiesterase expression in rat skeletal myoblasts. J Biol Chem. 1994;269: 8680-5.
32. Winter B, Braun T, Arnold HH. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-speci fic helix-loop-helix transcription factors Myf-5 and MyoD. J Biol Chem. 1993;268:9869-78.
33. Torday JS, Torres E, Rehan VK. The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation and repair in vitro. Pediatr Pathol Mol Med. 2003; 22(3):189-207.
34. Torday JS, Torday DP, Gutnick J, Qin J, Rehan VK. Biologic role of fibroblast triglycerides as antioxidants. Pediatr Res. 2001;49(6):843-9.
35. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. AJP-Renal Physiol. 1999;277(2):F157-75.
36. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147(12):5542-8.
37. Nguyen TM, Guillozo H, Marin L, Tordet C, Koite S, Garabedian G. Evidence for a vitamin D paracrine system regulating maturation of developing rat lung epithelium. Am J Physiol Lung Cell Mol Physiol. 1996;271(9):L392-9.
38. Nguyen M, Guillozo H, Marin L, et al. 1,25-Dihydroxyvitamin D3 receptors in rat lung during the perinatal period: regulation and immunocytochemical localization. Endocrinology. 1990;127:1755-62.
39. Marin L, Dufour ME, Nguyen TM, Tordet C, Garabedian M. Maturational changes induced by 1 alpha,25-dihydroxyvitamin D3 in type II cells from fetal rat lung explants. Am J Physiol. 1993;265:L45-52.
40. Leslie CC, McCormick-Shannon K, Cook JL, Mason RJ. Macrophages stimulate DNA synthesis in rat alveolar type II cells. Am Rev Res Dis. 1985;132:1246-52.
41. Marin L, Dufour ME, Tordet C, Nguyen M. 1,25(OH)2D3 stimulates phospholipid surfactant release in fetal rat lung explants. Biol Neonate. 1990;57:257-60.
42. Rooney SA. Glucocorticoid regulation of fatty acid synthase in fetal lung. In: Mendelson CR, editor. Endocrinology of the lung-Development and Surfactant Synthsis. New Jersey: Humana Press; 2000. p. 91-104.
43. Sakurai R, Shin E, Fonseca S, et al. 1a,25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipo fibroblast apoptosis. Am J Physiol Lung Cell Mol Physiol. 2009;297:L496-505.
44. Gaultier C, Harf A, Balmain N, Cuisinier-Gleizes P, Mathieu H. Lung mechanics in rachitic rats. Am Rev Respir Dis. 1984;130:1108-10.
45. Zosky GR, Berry LJ, Elliot JG, James AL, Gorman S, Hart PH. Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Respir Crit Care Med. 2011;183:1336-43.
46. Brun P, Dupret JM, Perret C, Thomasset M, Mathieu H. Vitamin D-dependent calcium-binding proteins (CaBPs) in human fetuses: comparative distribution of 9 K CaBP mRNA and K CaBP during development. Pediatr Res. 1987;21:362-7.
47. Stio M, Celli A, Lunghi B, Raugei G, Modesti A, Treves C. Vitamin D receptor in IMR-90 human fibroblasts and antiproliferative effect of 1,25-dihydroxyvitamin D3. Biochem Mol Biol Int. 1997;43:1173-81.
48. Lunghi B, Meacci E, Stio M, et al. 1,25-Dihydroxyvitamin D3 inhibits proliferation of IMR-human fibroblasts and stimulates pyruvate kinase activity in con fluent-phase cells. Mol Cell Endocrinol. 1995;115:141-8.
49. Rehan VK, Torday JS, Peleg S, et al. 1alpha,25-Dihydroxy-3epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab. 2002;76:46-56.
50. Phokela PS, Moya FR, Alcorn JL. Regulation of human pulmonary surfactant protein gene expression by 1alpha,25-dihydroxyvitamin D3. Am J Physiol Lung Cell Mol Physiol. 2005;289:L617-26.
51. Bosse Y, Lemire M, Poon AH, et al. Asthma and genes encoding components of the vitamin D pathway. Respir Res. 2009;10:98 [Published online 24 October 2009, doi:10.1186/1465- 9921-10-98].
52. Kho A, Bhattacharya S, Tantisira K, et al. Transcriptomic analysis of human lung development. Am J Resp Crit Care Med. 2010;181:54-63.
53. Glasgow JF, Thomas PS. Rachitic respiratory distress in small preterm infants. Arch Dis Child. 1977;52:268-73.
54. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128:3781-3.
55. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol. 2007;120:1031-5.
56. Devereux G, Litonjua AA, Turner SW, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007;85:853-9.
57. Camargo Jr CA, Rifas-Shiman SL, Litonjua AA, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 yrs of age. Am J Clin Nutr. 2007;85: 788-95.
58. Miyake Y, Sasaki S, Tanaka K, Hirota Y. Dairy food, calcium, and vitamin D intake in pregnancy and wheeze and eczema in infants. Eur Respir J. 2010;35:1228-34.
59. Erkkola M, Kaila M, Nwaru BI, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009;39:875-82.
60. Gosens R, Roscioni SS, Bart GJ, et al. Pharmacology of airway smooth muscle proliferation. Eur J Pharmacol. 2008;585:385-97.
61. Demay M. Muscle: a nontraditional 1, 25-dihydroxyvitamin D target tissue exhibiting classic hormone-dependent vitamin D receptor actions. Endocrinology. 2003;144:5135-7.
62. Song Y, Qi H, Wu C. Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology. 2007;12(4):486-94.
63. Atkinson J, Senior R. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003;28:12-24.
64. Coussens A, Timms P, Boucher B, et al. 1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology. 2009; 127:539-48.
65. Rehan VK, Torday JS. Perinatal vitamin D deficiency and childhood asthma: a molecular perspective. Curr Respir Med Rev. 2011;7:404-7.
66. Damera G, Fogle H, Lim P, et al. Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol. 2009;158:1429-41.
67. Gale CR, Robinson SM, Harvey NC, et al. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr. 2008;62:68-77.
68. Hypponen E, Sovio U, Wjst M, et al. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y Acad Sci. 2004;1037:84-95.
69. Wjst M, Dold S. Genes, factor X, and allergens: allergic diseases? Allergy. 1999;54(7): 757-9.
70. Torday JS, Rehan VK. Exploiting cellular-developmental evolution as the scienti fic basis for the preventive medicine. Med Hypothesis. 2009;72:596-602.
71. Sundh H, Larsson D, Sundell K. Environmental salinity regulates the in vitro production of [ 3 H]-1,25-dihydroxyvitamin D3 and [3 H]-24,25 dihydroxyvitamin D3 in rainbow trout (Oncorhynchus mykiss). Gen Comp Endocrinol. 2007;152:252-8.
72. Rehan VK, Dargan-Batra SK, Wang Y, et al. A paradoxical temporal response of the PTHrP/ PPARgamma signaling pathway to lipopolysaccharide in an in vitro model of the developing rat lung. Am J Physiol Lung Cell Mol Physiol. 2007;293:L182-90.
73. Gibson G. Decanalization and the origin of complex disease. Nat Rev Genet. 2009;10(2):134-40.
74. Waddington CH. Canalization of development and the inheritance of acquired characters. Nature. 1942;150:563-5.
75. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008;181(10):7090-9.
76. Ong PY, Hamid QA, Travers JB, et al. Decreased IL-15 may contribute to elevated IgE and acute in flammation in atopic dermatitis. J Immunol. 2002;168:505-10.
77. Bostrom H, Willetts K, Pekny M, et al. PDGF-A signaling is a critical event in lung alveolar myo fibroblast development and alveogenesis. Cell. 1996;85:863-73.
78. Pedigo N, Zhang H, Koszewski NJ, Kaetzel DM. A 5 -distal element mediates vitamin D-inducibility of PDGF-A gene transcription. Growth Factors. 2003;21:151-60.
79. Ormerod A, Xing Z, Pedigo N, Mishra A, Kaetzel D. The calcitriol analogue EB1089 impairs alveolarization and induces localized regions of increased fibroblast density in neonatal rat lung. Exp Lung Res. 2008;34:155-82.
80. Oyewumi L, Kaplan F, Sweezey NB. Lgl1, a mesenchymal modulator of early lung branching morphogenesis, is a secreted glycoprotein imported by late gestation lung epithelial cells. Biochem J. 2003;376:61-9.
81. Nadeau K, Montermini L, Mandeville I, et al. Modulation of 469 Lgl1 by steroid, retinoic acid, and vitamin D models complex transcriptional regulation during 470 alveolarization. Pediatr Res. 2010;67:375-81.
82. Filby CE, Hooper SB, Sozo F, Zahra VA, Flecknoe SJ, Wallace MJ. VDUP1: a potential mediator of expansion-induced lung growth and epithelial cell differentiation in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2006;290:L250-8.
83. Ramirez A, Wongtrakool C, Welch T, Steinmeyer A, Zgel U, Roman J. Vitamin D inhibition of pro- fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol. 2010;118:142-50.
84. Coussens AK. Immunomodulatory actions of vitamin D metabolites and their potential relevance to human lung disease. Curr Respir Med Rev. 2011;7:444-53.
85. Devereux G, Wagner JG. Vitamin D and asthma: scienti fic promise and clinical reality. Curr Respir Med Rev. 2011;7:408-13.
86. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26-34.
87. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122:1142-52.
88. Bouillon R, Van Baelen H, DeMoor D. 25-Hydroxy-vitamin D and its binding protein in maternal and cord serum. J Clin Endocrinol Metab. 1977;45:679-84.
89. Ross R, Halbert K, Tsang RC. Determination of the production and metabolic clearance rates of 1,25-dihydroxyvitamin D3 in the pregnant sheep and its chronically catheterized fetus by primed infusion technique. Pediatr Res. 1989;26:633-8.
90. Rubin LP, Yeung B, Vouros P, et al. Evidence for human placental synthesis of 24,25-dihydroxyvitamin D3 and 23,25-dihydroxyvitamin D3. Pediatr Res. 1993;34:98-104.
91. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insuf ficiency: a genome-wide association study. Lancet. 2010;376(9736):180-8.
92. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol. 2010;121(1-2): 297-300.
93. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev. 2008;66(10 Suppl 2): S153-64.
94. Dijkstra SH, van Beek A, Janssen JW, de Vleeschouwer LH, Huysman WA, van den Akker EL. High prevalence of vitamin D deficiency in newborn infants of high-risk mothers. Arch Dis Child. 2007;92:750-3.
95. Hypponen E, Boucher BJ. Avoidance of vitamin D deficiency in pregnancy in the United Kingdom: the case for a uni fied approach in national policy. Br J Nutr. 2010;104(3):309-14.
96. Pittard 3rd WB, Geddes KM, Hulsey TC, Hollis BW. How much vitamin D for neonates? Am J Dis Child. 1991;145:1147-9.
97. Taylor SN, Hollis BW, Wagner CL. Vitamin D needs of preterm infants. Neoreviews. 2009;10:12e590-9.
98. Etches PC, Koo WW. Parental vitamins A, D, and E for premature infants. J Perinatol. 1988; 8(2):93-5.
99. Misra M, Pacaud S, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008; 122:398-417.
100. Koo WW, Krug-Wispe S, Neylan M, Succop P, Oestreich AE, Tsang RC. Effect of three levels of vitamin D intake in preterm infants receiving high mineral-containing milk. J Pediatr Gastroenterol Nutr. 1995;21:182-9.
101. Agostoni C, Buonocore G, Carnielli VP, et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010;50:85-91.
102. Rigo J, Pieltain C, Salle B, Senterre J. Enteral calcium, phosphate and vitamin D requirements and bone mineralization in preterm infants. Acta Paediatr. 2007;96:969-74.
103. Heubi JE, Hollis BW, Tsang RC. Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia. Pediatr Res. 1990;27:26-31.
104. Wagner CL, Johnson D, Hulsey TC, et al. Vitamin D supplementation during pregnancy. Part I. NICHD/CTSA Randomized Clinical Trial (RCT): safety considerations. Pediatr Acad Soc. [Abstract 2630.7].
105. Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J. Inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) on the G(1)-S phasecontrolling machinery. Mol Endocrinol. 2001; 15:1370-80.
106. Blauer M, Rovio PH, Ylikomi T, Heinonen PK. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil Steril. 2009;91:1919-25.